{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Gout+and+Hyperuricemia&page=2", "query": { "condition": "Gout and Hyperuricemia", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Gout+and+Hyperuricemia&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-07-24T16:09:06.326Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04070846", "title": "Mass Balance Study of [14C]LC350189 in Healthy Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Gout", "Hyperuricemia" ], "interventions": [ { "name": "[14C] LC350189", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "LG Chem", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "MALE", "summary": "18 Years to 55 Years · Male only" }, "enrollment_count": 6, "start_date": "2020-02-26", "completion_date": "2020-03-07", "has_results": false, "last_update_posted_date": "2020-06-26", "last_synced_at": "2026-07-24T16:09:06.326Z", "location_count": 1, "location_summary": "Austin, Texas", "locations": [ { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04070846" }, { "nct_id": "NCT05586958", "title": "Tigulixostat, Phase 3 Study, Placebo Controlled in Gout Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Gout", "Hyperuricemia", "Gout Flare", "Tophi" ], "interventions": [ { "name": "Tigulixostat", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "LG Chem", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 354, "start_date": "2022-10-25", "completion_date": "2024-12-16", "has_results": false, "last_update_posted_date": "2025-10-29", "last_synced_at": "2026-07-24T16:09:06.326Z", "location_count": 36, "location_summary": "Birmingham, Alabama • Covina, California • Clearwater, Florida + 31 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Covina", "state": "California" }, { "city": "Clearwater", "state": "Florida" }, { "city": "Coral Gables", "state": "Florida" }, { "city": "Hialeah", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05586958" }, { "nct_id": "NCT01082640", "title": "Effect of Febuxostat on Renal Function in Patients With Gout and Moderate to Severe Renal Impairment", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Renal Impairment" ], "interventions": [ { "name": "Febuxostat", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 96, "start_date": "2010-04", "completion_date": "2012-05", "has_results": true, "last_update_posted_date": "2013-09-25", "last_synced_at": "2026-07-24T16:09:06.326Z", "location_count": 58, "location_summary": "Birmingham, Alabama • Peoria, Arizona • Sierra Vista, Arizona + 55 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Peoria", "state": "Arizona" }, { "city": "Sierra Vista", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01082640" }, { "nct_id": "NCT00995618", "title": "Study of Tranilast Alone or in Combination With Febuxostat in Patients With Hyperuricemia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Gout", "Hyperuricemia" ], "interventions": [ { "name": "Tranilast", "type": "DRUG" }, { "name": "Febuxostat", "type": "DRUG" }, { "name": "Combination - Tranilast and Febuxostat", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Nuon Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 24, "start_date": "2009-09", "completion_date": "2010-04", "has_results": false, "last_update_posted_date": "2011-01-06", "last_synced_at": "2026-07-24T16:09:06.326Z", "location_count": 3, "location_summary": "Honolulu, Hawaii • Evansville, Indiana • Dallas, Texas", "locations": [ { "city": "Honolulu", "state": "Hawaii" }, { "city": "Evansville", "state": "Indiana" }, { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00995618" }, { "nct_id": "NCT07280156", "title": "A Study to Investigate the Clinical Effect and the Safety of PRX-115 Infused Intravenously at Different Dosing Regimens, With and Without Methotrexate, Versus Placebo in Adults Gout Patients (RELEASE)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Gout" ], "interventions": [ { "name": "PRX-115", "type": "BIOLOGICAL" }, { "name": "Methotrexate (MTX)", "type": "DRUG" }, { "name": "PRX-115 placebo", "type": "OTHER" }, { "name": "Placebo-Methotrexate", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "DRUG", "OTHER" ], "sponsor": "Protalix", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 150, "start_date": "2025-12-22", "completion_date": "2028-06", "has_results": false, "last_update_posted_date": "2026-06-11", "last_synced_at": "2026-07-24T16:09:06.326Z", "location_count": 18, "location_summary": "Little Rock, Arkansas • El Cajon, California • Clearwater, Florida + 12 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "El Cajon", "state": "California" }, { "city": "Clearwater", "state": "Florida" }, { "city": "DeLand", "state": "Florida" }, { "city": "Doral", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07280156" }, { "nct_id": "NCT01265264", "title": "Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral Ulodesine Added to Allopurinol", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Gout", "Hyperuricemia", "Arthritis", "Joint Disease" ], "interventions": [ { "name": "ulodesine", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "BioCryst Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "69 Years", "sex": "ALL", "summary": "18 Years to 69 Years" }, "enrollment_count": 279, "start_date": "2010-12", "completion_date": "2013-02", "has_results": false, "last_update_posted_date": "2013-11-20", "last_synced_at": "2026-07-24T16:09:06.326Z", "location_count": 54, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Phoenix, Arizona + 51 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT01265264" }, { "nct_id": "NCT07116746", "title": "Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment Failed Patients", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Gout", "Gouty Arthritis", "Hyperuricemia", "Gout Chronic", "Refractory Gout", "Uncontrolled Gout", "Tophaceous Gout" ], "interventions": [ { "name": "AR882 75 mg", "type": "DRUG" }, { "name": "XOI Low Dose", "type": "DRUG" }, { "name": "XOI High Dose", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Arthrosi Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 15, "start_date": "2025-12-03", "completion_date": "2027-02", "has_results": false, "last_update_posted_date": "2026-05-15", "last_synced_at": "2026-07-24T16:09:06.326Z", "location_count": 8, "location_summary": "Margate, Florida • Miami, Florida • Tampa, Florida + 5 more", "locations": [ { "city": "Margate", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Tampa", "state": "Florida" }, { "city": "Jackson", "state": "Mississippi" }, { "city": "Charlotte", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT07116746" }, { "nct_id": "NCT04060173", "title": "A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ABP-671", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Hyperuricemia", "Gout" ], "interventions": [ { "name": "ABP-671", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Atom Therapeutics Co., Ltd", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 27, "start_date": "2019-09-05", "completion_date": "2020-02-07", "has_results": false, "last_update_posted_date": "2020-02-12", "last_synced_at": "2026-07-24T16:09:06.326Z", "location_count": 1, "location_summary": "Tempe, Arizona", "locations": [ { "city": "Tempe", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT04060173" }, { "nct_id": "NCT05119686", "title": "Phase 2b Evaluation of Efficacy and Safety of AR882 in Gout Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Gout", "Arthritis, Gouty", "Hyperuricemia", "Gout Chronic" ], "interventions": [ { "name": "AR882 Dose 1", "type": "DRUG" }, { "name": "AR882 Dose 2", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Arthrosi Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 140, "start_date": "2021-11-16", "completion_date": "2022-11-17", "has_results": false, "last_update_posted_date": "2023-05-12", "last_synced_at": "2026-07-24T16:09:06.326Z", "location_count": 16, "location_summary": "Gilbert, Arizona • Sun City, Arizona • Tucson, Arizona + 12 more", "locations": [ { "city": "Gilbert", "state": "Arizona" }, { "city": "Sun City", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Miami", "state": "Florida" }, { "city": "Miami Lakes", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05119686" }, { "nct_id": "NCT07089888", "title": "A Study of Dotinurad Versus Allopurinol in Tophaceous Gout", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Tophaceous Gout" ], "interventions": [ { "name": "Allopurinol", "type": "DRUG" }, { "name": "Dotinurad", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Crystalys Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 250, "start_date": "2025-08-04", "completion_date": "2027-12-31", "has_results": false, "last_update_posted_date": "2026-05-20", "last_synced_at": "2026-07-24T16:09:06.326Z", "location_count": 86, "location_summary": "Birmingham, Alabama • Foley, Alabama • Gilbert, Arizona + 77 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Foley", "state": "Alabama" }, { "city": "Gilbert", "state": "Arizona" }, { "city": "Glendale", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT07089888" } ] }